Mind Medicine (MindMed) Inc. [NASDAQ: MNMD] price surged by 6.04 percent to reach at $0.2. The company report on May 19, 2021 that The Chopra Foundation and MindMed Enter Into Letter of Intent to Partner on the Future of Psychedelic Medicines & Mental Wellbeing.
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) (“MindMed” or the “Company”), a leading clinical stage psychedelic medicine company, announced it has entered into a letter of intent to partner with The Chopra Foundation to educate and build public awareness around the use of psychedelic medicines to treat mental illness, remove outdated stigmas, and ultimately research mental wellbeing approaches that can be used in psychedelic related psychotherapy.
The two organizations plan to design and conduct research together surrounding altered states of consciousness, psychedelic psychotherapy, and their overall impact on mental wellbeing. Beyond psychedelics, as part of this research, MindMed intends to explore ways for therapists to integrate evidence-based digital therapeutics and digital measurement technology into their routine practice. In addition, MindMed and the Chopra Foundation plan to advance research that targets understanding the role that the mind-body connection, metabolic health, psychedelics, and deeper understandings of consciousness can play into maintenance of overall wellbeing and mental health.
A sum of 8259260 shares traded at recent session while its average daily volume was at 6.26M shares. Mind Medicine (MindMed) Inc. shares reached a high of $3.55 and dropped to a low of $3.16 until finishing in the latest session at $3.51.
Guru’s Opinion on Mind Medicine [MindMed] Inc. [MNMD]:
The Average True Range (ATR) for Mind Medicine (MindMed) Inc. is set at 0.46
MNMD Stock Performance Analysis:
Mind Medicine (MindMed) Inc. [MNMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.96. With this latest performance, MNMD shares gained by 50.00% in over the last four-week period, additionally plugging by 284.87% over the last 6 months – not to mention a rise of 630.95% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MNMD stock in for the last two-week period is set at 55.44, with the RSI for the last a single of trading hit 57.59, and the three-weeks RSI is set at 54.40 for Mind Medicine (MindMed) Inc. [MNMD]. The present Moving Average for the last 50 days of trading for this stock 2.94, while it was recorded at 3.19 for the last single week of trading, and 2.08 for the last 200 days.
Insight into Mind Medicine [MindMed] Inc. Fundamentals:
Return on Total Capital for MNMD is now -79.31, given the latest momentum, and Return on Invested Capital for the company is -86.40. Return on Equity for this stock declined to -86.40, with Return on Assets sitting at -83.88.
Mind Medicine [MindMed] Inc. [MNMD] Insider Position Details
There are presently around $1 million, or 0.57% of MNMD stock, in the hands of institutional investors. The top three institutional holders of MNMD stocks are: TRU INDEPENDENCE LLC with ownership of 112,693, which is approximately New of the company’s market cap and around 6.56% of the total institutional ownership; GOFEN & GLOSSBERG LLC /IL/, holding 72,500 shares of the stock with an approximate value of $0.25 million in MNMD stocks shares; and FNY INVESTMENT ADVISERS, LLC, currently with $70000.0 in MNMD stock with ownership of nearly New of the company’s market capitalization.
Positions in Mind Medicine (MindMed) Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 5 institutional holders increased their position in Mind Medicine (MindMed) Inc. [NASDAQ:MNMD] by around 151,693 shares. Additionally, 1 investors decreased positions by around 2,249 shares, while 1 investors held positions by with 64,751 shares. The mentioned changes placed institutional holdings at 218,693 shares, according to the latest SEC report filing. MNMD stock had 4 new institutional investments in for a total of 143,693 shares, while 0 institutional investors sold positions of 0 shares during the same period.